Background Cryptococcal meningitis (CM) has a high morbidity and mortality due to the low detection of Cryptococcus in cerebrospinal fluid (CSF) during the early stage of the disease with traditional methods. Case presentation In addition to the traditional methods of India ink staining and cryptococcal antigen (CrAg), we used nanopore sequencing and next-generation sequencing (NGS) to detect pathogenic DNA in CSF samples of three patients with CM. The CSF samples of all three patients were positive by India ink staining and CrAg. NGS also detected Cryptococcus in all three CSF samples. Nanopore sequencing detected Cryptococcus in two CSF samples. Conclusion Nanopore sequencing may be useful in assisting with the clinical diagnosis of CM. Further research is needed to determine the sensitivity and specificity of nanopore sequencing of CSF.
Background Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a type of autoimmune encephalitis (AE) characterized by antibodies against NMDA receptor. As the most common autoimmune encephalitis, anti-NMDAR encephalitis, affects 54% ~ 80% of patients with AE. It is associated with a high percentage of severe illness. It typically manifests as behavioural and psychiatric disturbance, epilepsy, cognitive decline, decreased level of consciousness, involuntary movements, autonomic dysfunction, and central hypoventilation, et.al. Case presentation We report two refractory anti-NMDAR encephalitis. One of them decribes a case of anti-NMDA encephalitis coexisting with MOG antibodies. The two patients were administered first-line therapy with glucocorticoids and intravenous immunoglobulin but did not improved clinically. Therefore, the patient was switched to the fully human anti-CD20 monoclonal antibody, ofatumumab. Their consciousness, behavioural and psychiatric disturbance, and capacity to conduct daily tasks improved markedly after sequential therapy with ofatumumab, as demonstrated by the modified Rankin scale (mRS) score. Conclusion For the first time, we report a successful approach to the treatment of refractory anti-NMDAR encephalitis using the fully human anti-CD20 monoclonal antibody ofatumumab, which serves as an important reference for the treatment of autoimmune encephalitis.
Purpose: Many moyamoya disease (MMD) ischemic strokes were misdiagnosed and could not be treated effectively. To address this question, we aimed to screen easily obtainable clinical variables to construct a differential diagnostic model between MMD and non-MMD ischemic stroke. Methods: A total of 300 patients (150 MMD and 150 non-MMD ischemic strokes) in Henan Provincial People's Hospital were selected and divided into training (210) and validation cohorts (90). Binary logistic regression analysis, lasso regression, and support vector machine (SVM) were used to construct the diagnostic model. The optimal model was visualized by nomograms, and the discriminant ability of the nomogram was tested in the training and validation cohorts, respectively. Results: Among the three models, binary logistic regression has the most significant C statistic (0.87 and 0.88) in the training cohort and validation cohort, respectively. The variables that showed a significant difference in the multivariate logistic regression analysis were systolic blood pressure (SBP), total cholesterol (TC), albumin (ALB), free triiodothyronine (FT3), homocysteine (HCY), and age. The Hosmer-Lemeshow test P values of nomograms in the training and validation cohorts were 0.28 and 0.19, respectively, and the calibration curves were well corrected. Patients with nomogram scores below or above 168 were considered to have a low or high risk of ischemic stroke in MMD, respectively. Conclusion:Using nomograms to identify MMD and non-MMD ischemic stroke, the model has been validated to have a good discriminatory ability in both the training and validation cohorts, improving clinicians’ awareness of MMD ischemic stroke.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.